Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.



Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases

Author affiliations

Abstract

Amyloid diseases are global epidemics with no cure currently available. In the past decade, the use of engineered nanomaterials as inhibitors or probes against the pathogenic aggregation of amyloid peptides and proteins has emerged as a new frontier in nanomedicine. In this Minireview, we summarize for the first time the pivotal role of chemical synthesis in enabling the development of this multidisciplinary field.

Graphical abstract: Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases

Back to tab navigation

Article information


Submitted
04 Jun 2020
Accepted
30 Jun 2020
First published
30 Jun 2020

Nanoscale, 2020, Advance Article
Article type
Minireview

Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases

N. Andrikopoulos, Y. Li, L. Cecchetto, A. Nandakumar, T. Da Ros, T. P. Davis, K. Velonia and P. C. Ke, Nanoscale, 2020, Advance Article , DOI: 10.1039/D0NR04273K

Social activity

Search articles by author

Spotlight

Advertisements